Structure-activity relationship of human liver-expressed antimicrobial peptide 2

Peptides

Volumn 31, Issue 1, 2010, Pages 58-66

  Hocquellet, Agnès ^a   Odaert, Benoit ^b   Cabanne, Charlotte ^a   Noubhani, Abdelmajid ^a   Dieryck, Wilfrid ^a   Joucla, Gilles ^a   Le Senechal, Caroline ^a   Milenkov, Milen ^a   Chaignepain, Stéphane ^b,c   Schmitter, Jean Marie ^b   Claverol, Stéphane ^b   Santarelli, Xavier ^a   Dufourc, Erick J ^b   Bonneu, Marc ^a,b   Garbay, Bertrand ^a   Costaglioli, Patricia ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Institut de Biochimie et Genetique Cellulaires   (France)

Author keywords

Antimicrobial peptide; Disulfide bond; DNA binding; Structure activity relation

Indexed keywords

CYSTEINE; DISULFIDE; LIVER EXPRESSED ANTIMICROBIAL PEPTIDE 2; MAGAININ 2; PLASMID DNA; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN LEAP 2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS MEGATERIUM; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; BROTH DILUTION; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISULFIDE BOND; DRUG DNA BINDING; DRUG OXIDATION; DRUG SYNTHESIS; ESCHERICHIA COLI; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACILLUS MEGATERIUM; BLOOD PROTEINS; CELL MEMBRANE PERMEABILITY; DISULFIDES; DNA; HUMANS; MICROBIAL SENSITIVITY TESTS; OXIDATION-REDUCTION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

BACILLUS MEGATERIUM; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; POSIBACTERIA;

EID: 73049108637     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.10.006     Document Type: Article

References (37)

1. Bourbon C., Bry C., Roggemans C., Soulard C., Thizon C., and Garbay B. Use of a real-time polymerase chain reaction thermocycler to study bacterial cell permeabilization by antimicrobial peptides. Anal Biochem 381 (2008) 279-281
2. Bruhn O., Regenhard P., Michalek M., Paul S., Gelhaus C., Jung S., et al. A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function. Biochem J 407 (2007) 267-276
3. Campopiano D.J., Clarke D.J., Polfer N.C., Barran P.E., Langley R.J., Govan J.R.W., et al. Structure-activity relationships in defensins dimmers. A novel link between β-defensin tertiary structure and antimicrobial activity. J Biol Chem 279 (2004) 48671-48679
4. De Leeuw E., Burks S.R., Li X., Kao J.P.Y., and Lu W. Structure-dependent functional properties of human defensin 5. FEBS Lett 581 (2007) 515-520
5. De Smet K., and Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol Lett 27 (2005) 1337-1347
6. De Zelicourt A., Letousey P., Thoiron S., Campion C., Simoneau P., Elmorjani K., et al. Ha-DEF1, a sunflower defensin, induces cell death in Orobanche parasitic plants. Planta 226 (2007) 591-600
7. Ganz T. Molecular control of iron transport. J Am Soc Nephrol 18 (2007) 394-400
8. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J.J., Chertov O., et al. The structure of human β-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 275 (2000) 32911-32928
9. Jenssen H., Hamill P., and Hancock R.E.W. Peptide antimicrobial agents. Clin Microbiol Rev 19 (2006) 491-511
10. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., and Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273 (1998) 3718-3724
11. Kapust R.B., and Waugh D.S. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8 (1999) 1668-1674
12. Klüver E., Adermann K., and Schulz A. Synthesis and structure-activity relationship of β-defensins, multi-functional peptides of the immune system. J Pept Sci 12 (2006) 243-257
13. Klüver E., Schulz-Maronde S., Scheid S., Forssmann W.-G., and Adermann K. Structure-activity relation of human β-defensin 3: influence of disulfide bonds and Cys substitution on antimicrobial activity and cytotoxicity. Biochemistry 44 (2005) 9804-9816
14. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480 (2000) 147-150
15. Krause A., Sillard R., Kleemeier B., Kluver E., Maronde E., Conejo-Garcia J.R., et al. Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Protein Sci 12 (2003) 143-152
16. Krishnakumari V., Sharadadevi A., Singh S., and Nagaraj R. Single disulfide and linear analogues corresponding to the carboxy-terminal segment of bovine β-defensin-2: effects of introducing the β-hairpin nucleating sequence D-pro-gly on antibacterial activity and biophysical properties. Biochemistry 42 (2003) 9307-9315
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Mandal M., Jagannadham M.V., and Nagaraj R. Antibacterial activities and conformations of bovine β-defensin BNBD-12 and analogs: structural and disulfide bridge requirements for activity. Peptides 23 (2002) 413-418
19. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., and Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipids membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J 341 (1999) 501-513
20. Park C.B., Kim H.S., and Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244 (1998) 253-257
21. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
22. Pazgier M., and Lubkowski J. Expression and purification of recombinant human α-defensins in Escherichia coli. Protein Expr Purif 49 (2006) 1-8
23. Prinz W.A., Åslund F., Holmgren A., and Beckwith J. The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J Biol Chem 272 (1997) 15661-15667
24. Richard C., Drider D., Elmorjani K., Marion D., and Prévost H. Heterologous expression and purification of active divercin V41, a Class IIa bacteriocin encoded by a synthetic gene in Escherichia coli. J Bacteriol 186 (2004) 4276-4284
25. Roth B.L., Poot M., Yue S.T., and Millard P.J. Bacterial viability and antibiotic susceptibility testing with SYTOX Green nucleic acid stain. Appl Environ Microbiol 63 (1997) 2421-2431
26. Sang Y., Ramanathan B., Minton J.E., Ross C.R., and Blecha F. Porcine liver-expressed antimicrobial peptides, hepcidin and LEAP-2: cloning and induction by bacterial infection. Dev Comp Immunol 30 (2006) 357-366
27. Schagger H., and Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166 (1987) 368-379
28. Sharma S., and Khuller G. DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis. Curr Microbiol 43 (2001) 74-76
29. Tamamura H., Ikoma R., Niwa M., Funakoshi S., Murakami T., and Fujii N. Antimicrobial activity and conformation of tachyplesin I and its analogs. Chem Pharm Bull (Tokyo) 41 (1993) 978-980
30. Ulvatne H., Samuelsen Ø., Haukland H.H., Krämer M., and Vorland L.H. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. FEMS Microbiol Lett 237 (2004) 377-384
31. Varkey J., and Nagaraj R. Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines. Antimicrob Agents Chemother 49 (2005) 4561-4566
32. Wiegand I., Hilpert K., and Hancock R.E. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols 2 (2008) 163-174
33. Wu Z., Hoover D.M., Yang D., Boulegue C., Santamaria F., Oppenheim J.J., et al. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A 100 (2003) 8880-8885
34. Yonezawa A., Kuwahara J., Fujii N., and Sugiura Y. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Biochemistry 31 (1992) 2998-3004
35. Zasloff M., Martin B., and Chen H.-C. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci 85 (1988) 910-913
36. Zhang H., Yuan Q., Zhu Y., and Ma R. Expression and preparation of recombinant hepcidin in Escherichia coli. Protein Expr Purif 41 (2005) 409-416
37. Nemeth E., Preza G.C., Jung C.-L., Kaplan J., Waring A.J., and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107 (2006) 328-333